Extra-target low-risk prostate cancer: implications for focal high-intensity focused ultrasound of clinically significant prostate cancer

[1] Mottet N(2017)EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: Screening, diagnosis, and local treatment with curative intent Eur Urol 71 618-629

[2] Bellmunt J(2013)Long-term functional outcomes after treatment for localized prostate cancer N Engl J Med 368 436-445

[3] Bolla M(2017)New and established technology in focal ablation of the prostate: a systematic review Eur Urol 71 17-34

[4] Briers E(2015)Focal therapy: patients, interventions, and outcomes—a report from a consensus meeting Eur Urol 67 771-777

[5] Cumberbatch MG(2011)Quantitative tissue analyses of prostate cancer foci in an unselected cystoprostatectomy series BJU Int 110 517-523

[6] De Santis M(2008)Residual tumor potentially left behind after local ablation therapy in prostate adenocarcinoma J Urol 179 2203-2206

[7] Resnick MJ(1992)Multiple cancers in the prostate. Morphologic features of clinically recognized versus incidental tumors Cancer 70 2313-2318

[8] Koyama T(2009)Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer Nat Med 15 559-565

[9] Fan K-H(2009)The index lesion and the origin of prostate cancer N Engl J Med 361 1704-52

[10] Albertsen PC(2011)Histological characteristics of the index lesion in whole-mount radical prostatectomy specimens: implications for focal therapy Prostate Cancer Prostatic Dis 14 46-594

[1] Mottet N(2017)EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: Screening, diagnosis, and local treatment with curative intent Eur Urol 71 618-629

[2] Bellmunt J(2013)Long-term functional outcomes after treatment for localized prostate cancer N Engl J Med 368 436-445

[3] Bolla M(2017)New and established technology in focal ablation of the prostate: a systematic review Eur Urol 71 17-34

[4] Briers E(2015)Focal therapy: patients, interventions, and outcomes—a report from a consensus meeting Eur Urol 67 771-777

[5] Cumberbatch MG(2011)Quantitative tissue analyses of prostate cancer foci in an unselected cystoprostatectomy series BJU Int 110 517-523

[6] De Santis M(2008)Residual tumor potentially left behind after local ablation therapy in prostate adenocarcinoma J Urol 179 2203-2206

[7] Resnick MJ(1992)Multiple cancers in the prostate. Morphologic features of clinically recognized versus incidental tumors Cancer 70 2313-2318

[8] Koyama T(2009)Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer Nat Med 15 559-565

[9] Fan K-H(2009)The index lesion and the origin of prostate cancer N Engl J Med 361 1704-52

[10] Albertsen PC(2011)Histological characteristics of the index lesion in whole-mount radical prostatectomy specimens: implications for focal therapy Prostate Cancer Prostatic Dis 14 46-594